These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Possibilities and limits of evaluation research: development of evaluation methods with an example]. Niechzial M; Nagel E; Pichlmayr R Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():617-24. PubMed ID: 9574223 [TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
4. [Practice guidelines in rehabilitation: infringement upon physicians' autonomy or foundation for better outcomes?]. Brüggemann S; Korsukéwitz C Rehabilitation (Stuttg); 2004 Oct; 43(5):304-11. PubMed ID: 15472789 [TBL] [Abstract][Full Text] [Related]
5. [Economic and ethical aspects of the development of treatment guidelines]. Lauterbach KW Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):277-82. PubMed ID: 9312433 [TBL] [Abstract][Full Text] [Related]
6. [Significance of selected preventive, therapeutic and rehabilitation services reflected in a population survey]. Westphal R; Röstermundt A; Raspe H Gesundheitswesen; 2001 May; 63(5):302-10. PubMed ID: 11441673 [TBL] [Abstract][Full Text] [Related]
7. [Health care contract, economic options and budgeting in ambulatory care]. Richter-Reichhelm M Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):819-25; discussion 826-7. PubMed ID: 11190917 [TBL] [Abstract][Full Text] [Related]
8. [Economic limits in intensive care. Can we still afford intensive care in the year 2000?]. Barckow D Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):828-33; discussion 845. PubMed ID: 11190918 [TBL] [Abstract][Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
10. [Economic aspects of oncologic surgery: what do we know, are they relevant; must--may--we regard them?]. Nagel E; Meyer zu Vilsendorf A; Obermann K Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():91-7. PubMed ID: 9102021 [TBL] [Abstract][Full Text] [Related]
11. [Patient-oriented, treatment-accompanying documentation as a basis for evaluation with medical oncology as an example]. Hölzer S; Wächter W; Dudeck J Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):759-64. PubMed ID: 11127784 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities and limits of guidelines in medicine]. Lauterbach KW Z Arztl Fortbild Qualitatssich; 1998 Mar; 92(2):99-105. PubMed ID: 9577897 [TBL] [Abstract][Full Text] [Related]
18. [Guidelines in surgery: from the viewpoint of health care economics]. Neubauer G Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():72-3. PubMed ID: 9574100 [TBL] [Abstract][Full Text] [Related]
19. [Decreased medical performance or lowering the standard? From the view point of the German Hospital Society]. Wagner A Chirurg; 1998 Mar; 69(3):84-6. PubMed ID: 9576030 [No Abstract] [Full Text] [Related]
20. [Quality assurance of inpatient care--exemplified by surgery]. Ekkernkamp A Z Arztl Fortbild Qualitatssich; 1997 Feb; 91(1):69-73. PubMed ID: 9221208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]